January 2011, volume 4, number 4

Life sciences

 

EndoCeutics and Bayer sign a $300 million agreement

Further clinical development and marketing of Vaginorm, the molecule identified by the team headed by Dr. Fernand Labrie and used to treat the main problems associated with menopause, will be handled with the assistance of the multinational Bayer. A $330 million investment will facilitate the hiring of more than 100 employees by 2013.

 

Atrium Innovations consolidates its holdings in Europe

Atrium Innovations has acquired Minami Nutrition, a prestigious Belgian brand of high-quality omega-3 supplements distributed in various European countries.

 

Vaccines: Medicago and Genopole® to create new lab

Medicago will be collaborating in the creation of a research lab in the Genopole® biopark, specializing in vaccines and antigen targets, in partnership with units from the French research academy.

 

$2 million for two new health research chairs

Marie-Claude Vohl will be heading the Canada Research Chair on Applied Genomics in Nutrition and Health, while Shirley Fecteau will be heading the Canada Research Chair on Cognitive Neuroplasticity, which aims to provide an understanding of the human brain's decision-making mechanism.

 

Two products by Immanence Dermo Correction (IDC) win French beauty awards

The company's anti-wrinkle and skin toning products for men and women have been a big hit with French consumers, who give them high marks for quality and effectiveness. IDC's products, which won two of these prestigious awards, are distributed in Canada, France, Turkey, China and Japan.

 

CHUQ researcher’s article makes Science magazine’s Top 5

An article describing the relationship between blood platelets and inflammatory arthritis, published by Dr. Éric Boilard in the January 2010 issue of Science magazine, is among the Top 5 of the year according to the F1000 post-publication peer review (Faculty of 1000).

 

Dual award for Dr. Philippe Pibarot (CRIUCPQ)

Dr. Philippe Pibarot of the Research Centre of the Quebec City University Institute for Cardiology and Pneumology (CRIUCPQ) recently received the Canadian Cardiovascular Society's Research Award of Excellence, coupled with the Canadian Society of Echocardiography's Achievement Award recognizing the excellence and impact of his work in these areas.

 

New CCTT for orthotic and prosthetic devices in Quebec City

The creation of a new college centre for technology transfers (CCTT) offering R&D, technical support and training/information services in the orthotic and prosthetic devices sector has been green lighted by the Government of Quebec.

 

Lévis-based OmegaChem wins PerformAS award

At the closing ceremony for the eighth Forum of the Quebec Association for Chemistry Development and Innovation (ADICQ), the Quebec Department of Economic Development (MDEIE) presented the PerformAS award to Lévis-based OmegaChem in recognition of its creation and marketing of new fluorination agents used in drug manufacturing.